Listed by the USPTO as MCCOLLUM, ANDREA K
Tech Center 1600 • Art Units: 1646 1647 1674
This examiner grants 60% of resolved cases
MCCOLLUM, ANDREA K is assigned to Tech Center 1600 and Art Unit 1646. The record covers 625 resolved cases, with a 60.2% allowance rate and a median of 1141 days to allowance. The profile shows allowance in a majority of observed cases, but the timing indicates that prosecution may continue for an extended period before that outcome.
The interview lift is 33.3%, showing a positive association between interviews and allowance outcomes. The listed organizations are The Brigham and Women's Hospital Inc., Novartis AG, and Boehringer Ingelheim International GmbH. The associated firms are COOLEY LLP, FISH & RICHARDSON P.C. (TC), and Knobbe, Martens, Olson & Bear, LLP. Their recurring presence may help counsel locate relevant experience with this examiner's docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18558729 | TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS USING ANTI-BAFFR ANTIBODIES | Non-Final OA | NOVARTIS AG |
| 18353133 | ANTI-IL-36R ANTIBODY FORMULATIONS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17732926 | BLOOD-BASED BIOMARKERS AND USE THEREOF FOR TREATING CANCER | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 18021641 | METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18611364 | ST2 ANTIGEN BINDING PROTEINS | Non-Final OA | Amgen Inc. |
| 18015169 | BIOFLUID-BASED PROTEIN AND MIRNA BIOMARKERS FOR NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY | Non-Final OA | The United States Government as represented by the Department of Veterans Affairs |
| 18278931 | TEST FOR MILD COGNITIVE IMPAIRMENT | Final Rejection | OSAKA UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.2% of resolved applications examined by Andrea K Mccollum were allowed (625 resolved cases), compared with 40.9% across Art Unit 1646 over the last five years.
This examiner's interview lift is +33.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Andrea K Mccollum took 1,141 days on average from filing to allowance.
Andrea K Mccollum examines applications in Art Unit 1646 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
